Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire Allerbio is a French pharmaceutical company specializing in the development and manufacture of allergen extracts for the diagnosis and treatment of respiratory and venom allergies. Founded in 1994 and based in Vandeins, the company provides a wide range of skin prick tests and allergen immunotherapy (AIT) products. In 2006, it was acquired by Stallergenes, a global leader in allergy immunotherapy, and now operates as part of the Stallergenes Greer group. Its portfolio focuses on precision diagnostics and desensitization therapies for patients suffering from allergic conditions. The company maintains a significant manufacturing presence in France, producing standardized extracts for clinical use across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire Allerbio.